Gene editing flows to the lungs.
Science (New York, N.Y.), 384(6701): 1175-1176 PMID 38870313 DOI 10.1126/science.adq0059
Abstract
Intravenous targeting of airway basal cells for cystic fibrosis gene therapy overcomes lung barriers.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.